| 29th Jun 2017 7:00 am |
RNS |
Start of Savolitinib Global PRCC Phase III Trial |
| 22nd Jun 2017 7:00 am |
RNS |
Chi-Med starts Ph I/II Trial of HMPL 453 in China |
| 16th Jun 2017 9:57 am |
RNS |
Director's Share Dealing |
| 12th Jun 2017 7:00 am |
RNS |
Fruquintinib NDA for Advanced CRC Filed with CFDA |
| 6th Jun 2017 7:00 am |
RNS |
Phase III Fruquintinib Data presented at ASCO |
| 18th May 2017 7:00 am |
RNS |
Chi-Med Presents Clinical Data at ASCO 2017 |
| 28th Apr 2017 1:40 pm |
RNS |
Total Voting Rights |
| 27th Apr 2017 2:10 pm |
RNS |
Results of Annual General Meeting |
| 7th Apr 2017 7:00 am |
RNS |
Pre-clinical Data Presented at AACR |
| 31st Mar 2017 7:00 am |
RNS |
Total Voting Rights |
| 29th Mar 2017 8:07 am |
RNS |
Vesting of LTIP awards |
| 28th Mar 2017 11:00 am |
RNS |
Grant of Share Options under Share Option Scheme |
| 27th Mar 2017 7:00 am |
RNS |
2016 Annual Report and Notice of AGM |
| 24th Mar 2017 7:00 am |
RNS |
Appointment of Director |
| 21st Mar 2017 10:08 am |
RNS |
Chi-Med to host R&D Briefings |
| 20th Mar 2017 8:04 am |
RNS |
Directors' Share Dealing |
| 16th Mar 2017 11:25 am |
RNS |
Grant of Awards under Long Term Incentive Plan |
| 13th Mar 2017 7:00 am |
RNS |
Publication of Form 20-F |
| 13th Mar 2017 7:00 am |
RNS |
Final Results |
| 10th Mar 2017 8:11 am |
RNS |
Sulfatinib Phase Ib/II Results Presented at ENETS |
| 10th Mar 2017 7:18 am |
RNS |
Sulfatinib Phase Ib/II Results Presented at ENETS |
| 7th Mar 2017 11:49 am |
EQS |
Edison issues update on Hutchison China Meditech (HCM) |
| 3rd Mar 2017 7:00 am |
RNS |
Positive Fruquintinib Pivotal Phase III Results |
| 28th Feb 2017 10:20 am |
RNS |
Change of Directors |
| 20th Feb 2017 7:00 am |
RNS |
Start of Phase II Savolitinib PSC trial in China |
| 14th Feb 2017 7:07 am |
RNS |
Initiates Phase I of Novel FGFR Inhibitor HMPL-453 |
| 14th Feb 2017 7:00 am |
RNS |
Savolitinib PRCC Results Presentation at ASCO GU |
| 6th Feb 2017 7:00 am |
RNS |
Chi-Med to Announce 2016 Final Results |
| 1st Feb 2017 7:00 am |
RNS |
Change of Directors |
| 16th Jan 2017 10:48 am |
RNS |
Change of Directors |
| 16th Jan 2017 10:11 am |
RNS |
Change of Directors |
| 16th Jan 2017 7:30 am |
RNS |
Fruquintinib Phase I/II Clinical Data at ASCO GI |
| 16th Jan 2017 7:29 am |
RNS |
Sulfatinib Phase II Study in 2nd Line BTC in China |
| 16th Jan 2017 7:16 am |
RNS |
Fruquintinib Combination Study in 1st-Line NSCLC |
| 10th Jan 2017 7:00 am |
RNS |
Chi-Med Initiates HMPL-523 Clinical Trials |
| 30th Dec 2016 9:11 am |
RNS |
Total Voting Rights |
| 29th Dec 2016 7:40 am |
RNS |
Blocklisting Six Monthly Return |
| 20th Dec 2016 7:18 am |
RNS |
Director's Share Dealing |
| 14th Dec 2016 7:14 am |
RNS |
Director's Share Dealing |
| 6th Dec 2016 7:00 am |
RNS |
HMPL-523 Pre-clinical Data Presented at ASH |
